✓ No loaded language, vague sourcing, or framing detected.
The FDA's advisory committee will convene to discuss the possibility of updating the COVID-19 vaccine to address the XFG subvariant. The meeting is set for Thursday, May 28, 2026.
Our neutral summary
The FDA's advisory committee will convene to discuss the possibility of updating the COVID-19 vaccine to address the XFG subvariant. The meeting is set for Thursday, May 28, 2026.
The reporting belongs to The Hill; we don't reproduce it.
No note attached
on this article.
FDA advisers to weigh updated COVID vaccine targeting XFG subvariant
FDA Advisory Committee to Discuss Updated COVID Vaccine for XFG Subvariant